Pretreatment of SW480 tumour cells with monoclonal anti-human recombinant FasL reduced mesothelial apoptosis in co-culture models by 290% compared to non-pretreated controls (Figure 3, CC− vs CC+, P<0.001). Here, FASLG is linked to neoplasm.